ALEXION PHARMACEUTICALS INC 4
4 · ALEXION PHARMACEUTICALS INC · Filed Mar 1, 2017
Insider Transaction Report
Form 4
Carmichael Clare
SVP, Chief HR Officer
Transactions
- Sale
Common Stock, par value $.0001 per share
2017-02-28$131.71/sh−915$120,515→ 33,065 total - Award
Common Stock, par value $.0001 per share
2017-02-28+6,500→ 39,565 total - Award
Option to Purchase Common Stock
2017-02-28+12,800→ 25,600 totalExercise: $131.25From: 2018-02-28Exp: 2027-02-28→ Common Stock, par value $.0001 per share (12,800 underlying) - Sale
Common Stock, par value $.0001 per share
2017-02-27$131.20/sh−860$112,832→ 33,980 total - Sale
Common Stock, par value $.0001 per share
2017-03-01$132.50/sh−404$53,530→ 39,161 total
Footnotes (5)
- [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]Award of Restricted Stock Units under the 2004 Incentive Plan. 25% vests on each anniversary of the grant date.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.00 - $132.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F5]Stock option award under 2004 Incentive Plan. 25% vest on the first anniversary of the grant date, 1/16 every three months thereafter until fully vested over 4 years.